Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Matteo Monieri
Cetuximab-Conjugates Nanoparticles for the Treatment of Triple Negative Breast Cancer
Related publications
Targeting MYC for Triple-Negative Breast Cancer Treatment
Oncoscience
Cancer Research
Oncology
Cetuximab PET Delineated Changes in Cellular Distribution of EGFR Upon Dasatinib Treatment in Triple Negative Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Targeted Nanoparticles for Image-Guided Treatment of Triple-Negative Breast Cancer: Clinical Significance and Technological Advances
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
Medicine
Bioengineering
Nanotechnology
Biomedical Engineering
Nanoscience
Triple-Negative Breast Cancer
Silencing the Roadblocks to Effective Triple-Negative Breast Cancer Treatments by siRNA Nanoparticles
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Systemic Administration of siRNA With Anti-Hb-Egf Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer
Layer-By-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment
ACS Nano
Materials Science
Nanoscience
Engineering
Nanotechnology
Astronomy
Physics
Platinum-Based Therapy for Triple-Negative Breast Cancer Treatment: A Meta-Analysis
Molecular and Clinical Oncology
Cancer Research
Oncology
Triple Negative Breast Cancer: Breast Cancer Research in Evolution
Breast Disease
Medicine
Cancer Research
Oncology